G1 Therapeutics, Inc. Common Stock
GTHX
GTHX was delisted on the 17th of September, 2024.
100 hedge funds and large institutions have $320M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 19 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 28
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
2% more funds holding
Funds holding: 98 → 100 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
60% less capital invested
Capital invested by funds: $798M → $320M (-$478M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.86M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$1.76M |
| 3 |
Morgan Stanley
New York
|
+$1.54M |
| 4 |
3C
361 Capital
Denver,
Colorado
|
+$1.02M |
| 5 |
Two Sigma Investments
New York
|
+$1.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$27M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$16.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.77M |
| 4 |
WJWM
Williams Jones Wealth Management
New York
|
-$4.19M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$1.05M |
GTHX Hedge Fund Activity: Q1 2020 in Review
100 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2020, worth a combined $320M — down 60% from $798M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new GTHX positions and 19 closed out — a net gain of 3 holders — while 34 added to existing stakes and 28 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $7.86M. The largest seller was Wellington Management Group, cutting an estimated $27M.
- 100 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2020, up from 98 in Q4 2019.
- Funds reported $320M of G1 Therapeutics, Inc. Common Stock stock for Q1 2020, down 60% quarter-over-quarter.
- 22 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2020 and 19 closed out, a net change of +3 holders.
- The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2020 was Deutsche Bank, an estimated $7.86M added.
- The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2020 was Wellington Management Group, an estimated $27M sold.
Based on aggregated 13F filings for Q1 2020.